key: cord-0852402-gnv26417
authors: Rogers, Jonathan P; Chesney, Edward; Oliver, Dominic; Pollak, Thomas A; McGuire, Philip; Fusar-Poli, Paolo; Zandi, Michael S; Lewis, Glyn; David, Anthony S
title: Psychiatric and neuropsychiatric syndromes and COVID-19 – Authors' reply
date: 2020-07-23
journal: Lancet Psychiatry
DOI: 10.1016/s2215-0366(20)30304-7
sha: 48e0c37a36e41753a6493e7d5b89201c0f0c1284
doc_id: 852402
cord_uid: gnv26417

nan

pathways might therefore be different to ARDS and it is difficult to draw direct comparison in relation to psychiatric outcomes at 1 year. We agree that to delineate causation between COVID-19 and subsequent psychiatric outcomes with the current evidence is difficult given the poor quality in methodology in some of the studies cited. A high level of evidence for psychological co-morbidity already existed before COVID-19-eg, posttraumatic stress disorder (PTSD) following general admission to intensive care unit (ICU) has a point prevalence of 34%, 3 which is similar to the overall point prevalence of 32·2% for PTSD in severe acute respiratory syndrome coronavirus 2 cited by the authors.

Although the authors acknowledge that the cause of psychiatric consequences is multifactorial, a more robust exploration of the role of medical interventions is required within an ICU context, including duration of sedation and the results of the severity of illness scoring system such as APACHE II. The type of sedation also has a key role in delirium, with many ICUs in the UK resorting to second-line agents during the COVID-19 pandemic due to resource constraints. 4 These second-line agents include long-acting benzodiazepines and opiates that have longer contextsensitive half-lives compared to first-line. Further qualitative data are required to examine COVID-19-related factors, such as fears that patients can experience on seeing staff in full personal protective equipment and challenges with communication following tracheostomy.

Categorisation of COVID-19 patients admitted to ICU would be useful, given these patients are not a homogenous group; sub-group classification into high dependency care patients and intensive care patients is one suggestion. Our preliminary local experience of using the acute stress disorder scale (which has a reasonable positive predictive value for future We 

We are grateful for the letters received regarding our Article, 1 which highlight the interest in this field and raise relevant clinical hypotheses. These letters illustrate a fundamental question: does infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lead to psychiatric and neuropsychiatric morbidity merely because COVID-19 is a severe illness or because of specific factors related to this infection? There are numerous-but still comparatively rare-examples of specific neuropsychiatric presentations of COVID-19 being collated in an online blog for the Journal of Neurology, Neurosurgery & Psychiatry. 2 Yi-Min Wan and colleagues are correct that anosmia requires more contribution to The Lancet Psychiatry, Eiko Fried and colleagues 1 note 10 377 unique symptom profiles for major depression, a number that only increases when the specifier, melancholia, is considered (ie, generating 341 737 unique profiles). Obviously, this is not so much an empirical discovery, as a logical consequence of the operational decision to define disorders in terms of additive independent criteria; the more criteria, the more possible combinations, and the more potential diagnostic heterogeneity.

It remains unclear, however, which precise lessons we should take home from this mathematical reductio ad absurdum.

A first possible lesson might emphasise the urgent need to critically reconsider the larger operational approach to psychiatric diagnosis itself. Apart from the artificial inflation of diagnostic heterogeneity stressed by the authors, 1 operationalism also resulted in an overly simplified approach to the psychopathological description of syndromes and symptoms. 2 In the case of melancholic depression, for example, this simplification prompted a questionable expansion of the concept to include an all-embracing class of various states of general unhappiness, with indistinct boundaries to states of normal psychology. 3 On this account, what is needed is not so much a discarding or downgrading of traditional diagnostic categories, such as melancholia or schizophrenia, but rather a resuscitation of detailed psychopathological understanding and assessment beyond the checklistapproach of counting criteria and symptoms. 4 However, this does not seem to be the lesson presented by the authors. 1 In fact, rather than exposing the absurdity of the operationalcriteriological approach to psychiatric diagnosis through their mathematical exercise, they assume the validity of the operational approach to challenge attention, as do stroke and other neurological conditions. Current literature has not often systematically assessed anosmia, 3 and pathological studies have been unable to elucidate whether this symptom is due to direct infection or secondary to mucosal involvement. 4 Vijay Pattni and colleagues correctly observe that the frequency of posttraumatic stress disorder (PTSD) following admission to an intensive treatment unit is high, regardless of the illness. However, it is also probable that factors specific to the current pandemic are relevant, such as extreme social isolation, staff wearing full personal protective equipment, health-care professionals working outside their primary area of expertise, treatment with corticosteroids, and use of second-line agents for sedation. Current naturalistic studies struggle to disentangle these issues.

Any recommendations should be proportionate and evidencebased. Pattni and colleagues suggest screening to identify patients at risk of developing PTSD, but we should exercise caution, 5 since outcomes could be variable and targeting individuals who have yet to develop a psychiatric disorder could have unintended consequences. 6 Before implementing novel interventions, further research is required to identify an evidence base and subsequently establish clinical guidelines for minimising psychological harm after infection with SARS-CoV-2. Equally important, as suggested by Latha Velayudhan and colleagues, is implementation of existing evidence, such as appropriate management of delirium, which is likely to be seen frequently.

JPR and EC contributed equally to this work. MSZ reports receiving personal fees from UCB Pharma for lecturing, outside the submitted work. PF-P reports personal fees from Lundbeck, outside the submitted work. All other authors declare no competing interests. 

The introduction of polythetic diagnostic criteria and their operational definitions from DSM-III onwards has been a mixed blessing for clinical and scientific psychiatry. While enhancing reliability and standardisation in research and practice, it has also led to several unintended and undesirable consequences.

Chief amongst these consequences is the well known problem of diagnostic heterogeneity. In their recent

BMJ blog: the neurology and neuropsychiatry of COVID-19

Impact of coronavirus syndromes on physical and mental health of health care workers: systematic review and meta-analysis

Neuropathological features of Covid-19

The role of screening in the prevention of psychological disorders arising after major trauma: pros and cons

Psychological debriefing for preventing post traumatic stress disorder (PTSD)